200
Views
2
CrossRef citations to date
0
Altmetric
Article

Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer

, &
Pages 261-279 | Received 03 Jan 2021, Accepted 01 Feb 2021, Published online: 28 Apr 2021

References

  • Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol. 2005;32(3):169–176. doi:10.1165/rcmb.F290.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer J Clin. 2020;70:7–30.
  • Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med. 2005;352(26):2714–2720. doi:10.1056/NEJMcp042630.
  • Liotta LA, Petricoin E. Cancer biomarkers: Closer to delivering on their promise. Cancer Cell. 2011;20(3):279–280. doi:10.1016/j.ccr.2011.08.021.
  • Minna JD. 2006. Neoplasms of the lung. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, ed(s). Harrison's Principles of Internal Medicine. 16th ed. Chapter 75. New York: McGraw-Hill Co, Inc; 2005. pp. 506–515.
  • Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol. 2007;2(4):327–343. doi:10.1097/01.JTO.0000263718.69320.4c.
  • Engelman JA, Janne PA. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clin Cancer Res. 2008;14(10):2895–2899. doi:10.1158/1078-0432.CCR-07-2248.
  • Knight ZA, Lin H, Shokat KM. Targeting the cancer kinome through polypharmacology. Nat Rev Cancer. 2010;10(2):130–137. doi:10.1038/nrc2787.
  • Esko JD, Lindahl U. Molecular diversity of heparan sulfate. J Clin Invest. 2001;108(2):169–173. doi:10.1172/JCI200113530.
  • Rosen SD, Lemjabbar-Alaoui H. Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets. 2010;14(9):935–949. doi:10.1517/14728222.2010.504718.
  • Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem. 2002;277(51):49175–49185. doi:10.1074/jbc.M205131200.
  • Bret C, Moreaux J, Schved JF, Hose D, Klein B. SULFs in human neoplasia: implication as progression and prognosis factors. J Transl Med. 2011;9(1):72–72. doi:10.1186/1479-5876-9-72.
  • Lemjabbar-Alaoui H, van Zante A, Singer MS, et al. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene. 2010;29(5):635–646. doi:10.1038/onc.2009.365.
  • Phillips JJ, Huillard E, Robinson AE, et al. Heparan sulfate sulfatase SULF2 regulates PDGFRalpha signaling and growth in human and mouse malignant glioma. J Clin Invest. 2012;122(3):911–922. doi:10.1172/JCI58215.
  • Lai JP, Oseini AM, Moser CD, et al. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. Hepatology. 2010;52(5):1680–1689. doi:10.1002/hep.23848.
  • Lui NS, Yang YW, van Zante A, Buchanan P, Jablons DM, Lemjabbar-Alaoui H. SULF2 expression is a potential diagnostic and prognostic marker in lung cancer. PLoS One. 2016;11(2):e0148911. doi:10.1371/journal.pone.0148911.
  • Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007;316(5827):1039–1043. doi:10.1126/science.1141478.
  • Lei W, Mayotte JE, Levitt ML. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells. Anticancer Res. 1999;19:221–228.
  • Uchimura K, Morimoto-Tomita M, Bistrup A, et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 2006;7:2. doi:10.1186/1471-2091-7-2.
  • Uchimura K, Morimoto-Tomita M, Rosen SD. Measuring the activities of the sulfs: two novel heparin/heparan sulfate endosulfatases. Methods Enzymol. 2006;416:243–253. doi:10.1016/S0076-6879(06)16015-2.
  • Singer MS, Phillips JJ, Lemjabbar-Alaoui H, et al. SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis. Clin Chim Acta. 2015;440:72–78. doi:10.1016/j.cca.2014.10.038.
  • Gill RB, Day A, Barstow A, Liu H, Zaman G, Dhoot GK. Sulf2 gene is alternatively spliced in mammalian developing and tumour tissues with functional implications. Biochem Biophys Res Commun. 2011;414(3):468–473. doi:10.1016/j.bbrc.2011.09.088.
  • Narita K, Staub J, Chien J, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 2006;66(12):6025–6032. doi:10.1158/0008-5472.CAN-05-3582.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.